---
schema_version: "secwatch.filing_event.v1"
accession: "0001437749-22-010347"
form_type: "8-K"
ticker: "AURX"
cik: "0001091596"
company_name: "Nuo Therapeutics, Inc."
filed_at: "2022-05-02T23:59:59+00:00"
generated_at: "2026-06-26T01:54:10.495036+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Nuo Therapeutics raises $3.55M in private placement at $1.00/share with insider participation

## Summary
- Sold 3,550,000 shares of common stock at $1.00 per share for gross proceeds of $3,550,000.
- Insider investors include CEO/CFO David Jorden ($10,532), director Scott Pittman ($100,000), COO Peter Clausen ($25,000), and principal holder Charles Sheedy ($804,868).
- Proceeds to be used for working capital; post-offering shares outstanding increase to 40,674,205.
- Shares issued under Section 4(a)(2) and Rule 506 in unregistered transaction; company not current in SEC reports.

## SEC filing metadata
- accession: 0001437749-22-010347
- form_type: 8-K
- ticker: AURX
- cik: 0001091596
- company_name: Nuo Therapeutics, Inc.
- filed_at: 2022-05-02T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 1.01, 3.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1091596/000143774922010347/0001437749-22-010347-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1091596/000143774922010347/aurx20220427_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001437749-22-010347
- JSON: https://secwatch.observer/filing/0001437749-22-010347.json
- Plain text: https://secwatch.observer/filing/0001437749-22-010347.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.